Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

NEOGAP Therapeutics AB

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 244 More Arrow 1,206 More Arrow 1,365
Earnings before taxes -11,593 Less Arrow -57,260 More Arrow -9,858
EBITDA -5,526 More Arrow -2,437 Less Arrow -8,748
Total assets 123,748 Less Arrow 60,133 More Arrow 121,370
Current assets 56,836 Less Arrow 23,699 More Arrow 48,125
Current liabilities 20,372 Less Arrow 3,877 More Arrow 4,338
Equity capital 49,180 Less Arrow 5,650 More Arrow 64,859
- share capital 135 Less Arrow 75 Less Arrow 49
Employees (average) 14 Equal arrow 14 Less Arrow 13

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 39.7% Less Arrow 9.4% More Arrow 53.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -9.2% Less Arrow -93.2% More Arrow -7.0%
Current ratio 279.0% More Arrow 611.3% More Arrow 1109.4%
Return on equity (ROE) -23.6% Less Arrow -1013.5% More Arrow -15.2%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 More Arrow 3
Chg. No. of employees % 0% More Arrow 8% More Arrow 30%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.